PECAM1 and type 2 diabetes mellitus: This could be primarily attributed to decreased expression of CD16 (P = 0.01) as well as of endothelial markers CD105 (P < 0.0001) and CD31 (P = 0.01) that was significantly lower among CD14+ monocyte-derived cells in patients with T2DM compared to controls (Figure 1D).